ATOVACON IN FORM OF PARTICLES, MICROFLUIDIZED ATOVACON PARTICLES, PHARMACEUTICAL COMPOSITION CONTAINING ATOVACON PARTICLES AND METHOD OF ITS PREPARING Russian patent published in 1999 - IPC

Abstract RU 2127585 C1

FIELD: medicine, pharmacy. SUBSTANCE: invention proposes microfluidized particles of atovacon and a method of their preparing. Invention deals also with a drug containing microfluidized particles of atovacon. The volume diameter of particles, at least 90% of their total amount, is 0.1-3 mcm. EFFECT: enhanced biological availability of atovacon. 16 cl, 2 tbl, 3 ex

Similar patents RU2127585C1

Title Year Author Number
WATER-DISPERSIBLE TABLETS, METHOD FOR THERI PREPARING, AND GRANULES AND DISPERSING AGENT FOR THEIR PRODUCTION 1992
  • Kristina Ehl'Zhbeta Fil'Den[Gb]
RU2106861C1
APPLICATION OF 5-ETHYNYLURACIL AS AN ACTIVATOR OF URACIL-REDUCTASE, PHARMACEUTICAL COMPOSITION, METHOD FOR ITS OBTAINING, PHARMACEUTICAL COMPOSITION FOR INCREASING THE ACTION OR DECREASING THE TOXICITY OF 5-FLUOURACIL 1991
  • Spektor Tomas
  • Porter Dehvid Dzhon Timoti
  • Rakhim Saad Dzhordzh
RU2194511C2
METHOD OF HEPATITIS B TREATMENT 1992
  • Fillip Allen Furman
  • Dzhordzh Robert Pejnter Iii[Us]
RU2104700C1
ENANTIOMERIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 1992
  • Susan Mehri Daludzh[Us]
RU2091386C1
METHOD OF SYNTHESIS OF ENANTIOMERIC COMPOUNDS OR THEIR DERIVATIVES 1990
  • Susan Mehri Daludzh[Us]
RU2068849C1
PYRIMIDINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION 1989
  • Ehlistehjr Ehjnsli Miller
  • Mal'Kol'M Stjuart Nobbz
  • Richard Martin Gajd
  • Majkl Dzhon Lich
RU2121998C1
METHOD FOR TREATING AND/OR PROPHYLAXIS OF PROTOZOAN PARASITARY INFECTION, USE OF ATOVACUON AND PROGUANYL FOR PRODUCING MEDICINAL PREPARATION FOR TREATING PROTOZOAN INFECTIONS, COMBINATION OF ATOVACUON WITH PROGUANYL FOR TREATING PROTOZOAN INFECTIONS, USE OF SAID COMBINATION AND PHARMACEUTICAL PREPARATION 1993
  • Uinston Ehdvard Gatteridzh[Gb]
  • Dehvid Brajan Ehshton Khatchinson[Gb]
  • Viktorija S'Juzn Lehtter[Gb]
  • Mehri Padni[Gb]
RU2108092C1
N,N-DIMETHYL-2-(5-(2-OXO-1,3-OXAZOLIDINE-4-YL-METHYL)-1H-INDO- -LE-3-YL)-ETHYLAMINE, ITS PHYSIOLOGICALLY ACCEPTABLE SALT OR SOLVATE, METHOD OF ITS SYNTHESIS, DRUG USED AS AN AGONIST OF "5-HT-LIKE" RECEPTOR IN MAMMALS, METHOD OF DRUG AGENT PREPARING 1991
  • Alan Dunkan Robertson[Gb]
  • Alan Piter Khill[Gb]
  • Robert Cherl'Z Glen[Gb]
  • Grehm Richard Martin[Gb]
RU2110517C1
METHOD OF PRODUCING BICYCLIC COMPOUNDS OR ADDITIVE SALTS OF HYDROCHLORIC ACID THEREOF 0
  • Uillyam Richard King
SU1384200A3
NERVOUS-MUSCLE BLOCKATOR, ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF PROVIDING NERVOUS-MUSCLE BLOCKADE IN ANIMALS 1991
  • Derek Ehntoni Khill[Gb]
  • Dzheffri Llojd Terner[Gb]
RU2104005C1

RU 2 127 585 C1

Authors

Alan Roj Dirn

Dates

1999-03-20Published

1993-12-23Filed